AMBIENT CONTAMINATION AND CAREGIVER PROTECTION DURING AEROSOL ANTIBIOTIC ADMINISTRATION.
One vial (5 mL, 300 mg) of Tobi (tobramycin solution for inhalation, Chiron, Emeryville, CA) was placed into the nebulizer. The following conditions were tested in a patient room: 1) a baseline 1 hr sample with no aerosol generated during the sample period, 2) 1 hr sample with a simulated Tobi treatment at the beginning of the sample period, 3) a simulated ...
AMBIENT CONTAMINATION AND CAREGIVER PROTECTION DURING AEROSOL ANTIBIOTIC ADMINISTRATION.
One vial (5 mL, 300 mg) of Tobi (tobramycin solution for inhalation, Chiron, Emeryville, CA) was placed into the nebulizer. The following conditions were tested in a patient room: 1) a baseline 1 hr sample with no aerosol generated during the sample period, 2) 1 hr sample with a simulated Tobi treatment at the beginning of the sample period, 3) a simulated ...
Antibiotics for cystic fibrosis - [Medication] - Quest Diagnostics Patient Health Library
Antibiotics for cystic fibrosis Examples Brand Name Chemical Name - ciprofloxacin - ofloxacin - tobramycin (including TOBI, an aerosol antibiotic that is used to treat lung infections) - gentamicin - azithromycin - ceftazidime Keflex cephalexin Ceclor cefaclor - piperacillin - imipenem How It Works Antibiotics kill bacteria that cause infection. Topic Contents -...
Chiron Corporation - Business - Business Units - Chiron BioPharmaceuticals
Leading products include TOBI ® tobramycin solution for inhalation, PROLEUKIN® (aldesleukin) interleukin-2 and BETASERON® INTERFERON BETA-1b.TOBI ® tobramycin solution for inhalation For treatment of Pseudomonal lung infections in cystic fibrosis patients PROLEUKIN® (aldesleukin) interleukin-2 For treatment of adults with metastatic renal...
Chiron Corporation - Physicians - Research & Development
Our Focus Chiron is applying an advanced understanding of cancer and infectious disease to create high-value products that address major medical needs. The company has maintained and broadened its focus on infectious-disease research since its groundbreaking work with hepatitis B antigens in the early 1980s. Product Franchises Chiron is building strong product lines in its...
Chiron Corporation - Physicians - History & Milestones
For more than 20 years, Chiron has been an industry leader, making groundbreaking scientific discoveries and creating revolutionary products that are improving human health worldwide. BETASERON ® INTERFERON BETA-1b gains expanded U.S. PROCLEIX ® System , a state-of-the-art blood-screening product, launched in the United States.TOBI ® tobramycin ...
Chiron Corporation - Business - Business Model - Key Product Franchises
- - Chiron’s product franchises provide physicians and patients with a growing portfolio of innovative products and services that offer improved effectiveness, convenience and safety. Inhaled Antibiotics Franchise TOBI ® tobramycin solution for inhalation is the cornerstone of Chiron's inhaled antibiotics franchise. The company is working to expand this...
Chiron Corporation - Research - History
- - For more than 20 years, Chiron has been an industry leader, making groundbreaking scientific discoveries and creating revolutionary products that are improving human health worldwide. Food and Drug Administration (FDA) labeling approval for treating relapsing forms of multiple sclerosis. Matrix Pharmaceutical Inc.TOBI ® tobramycin solution for inhalation...
Chiron Corporation - Pipeline - BioPharmaceuticals Pipeline
- - Description Preclinical Phase 1 Phase 2 Phase 3 Registration PULMINIQ™ (cyclosporine, USP) inhalation solution CUBICIN® (daptomycin for injection) Tifacogin Tobramycin inhalation powder (TIP) Monoclonal Antibodies Combination Therapies Description Preclinical Phase 1 Phase 2 Phase 3 Registration PROLEUKIN® (aldesleukin) - PEaRL Novel Agents Description...
http://www.novartis.com/downloads/20051031_Slides_for_conference_call_on_acquisition_of_remaining_Chiron_stake.pdf
Unlocking Chiron' s Potential Creating a Global Vaccines Platform 2 Agreement to acquire remaining stake of Chiron/ 31 October 2005 The following information contains certain Forward- looking Statements" within the meaning of the US Private Securities Litigation Reform Act, which can be identified by the use of forward looking terminology such as will", "grow into", ...
duplicates:http://www.novartis.com/downloads_new/investors/Conference_call_slides_Chiron.pdf http://www.novartis.com/downloads/20051031_Slides_for_conference_call_on_acquisition_of_remaining_Chiron_stake.pdf
http://www.novartis.com/downloads/20051031_Slides_for_conference_call_on_acquisition_of_remaining_Chiron_stake.pdf page 13
duplicates:http://www.novartis.com/downloads_new/investors/Conference_call_slides_Chiron.pdf http://www.novartis.com/downloads/20051031_Slides_for_conference_call_on_acquisition_of_remaining_Chiron_stake.pdf
Chiron Media Kit page 16
author: Chiron Corporation
subject: For your convenience, printable versions of key information from various sections of our corporate site can be found here in PDF format. To the best of Chiron s knowledge, all information included is timely and accurate as of the date originally issued.
duplicates:http://www.chiron.com/media/mediakit/media_fact_sheet.pdf
Chiron Media Kit page 2
author: Chiron Corporation
subject: For your convenience, printable versions of key information from various sections of our corporate site can be found here in PDF format. To the best of Chiron s knowledge, all information included is timely and accurate as of the date originally issued.
duplicates:http://www.chiron.com/media/mediakit/media_chiron_history.pdf
Chiron Media Kit
Howard Pien Chief Executive Officer and Chairman of the Board, Chiron Corporation Raymund Breu, Ph. acquired.TOBI ® tobramycin solution for inhalation, the first inhaled antibiotic approved for treating lung infections in cystic fibrosis patients, launched in Europe. Hepatitis B antigens discovered and cloned; technology used to develop the first...
author: Chiron Corporation
subject: For your convenience, printable versions of key information from various sections of our corporate site can be found here in PDF format. To the best of Chiron s knowledge, all information included is timely and accurate as of the date originally issued.
Chiron Fact Sheet
Through its global Blood Testing, Vaccines and BioPharmaceuticals businesses, Chiron Corporation addresses human suffering with more than 50 diverse products to detect, prevent and treat disease worldwide. Chiron believes that science has the power to improve people's lives and harnesses that power to transform human health. Chiron Blood Testing Chiron Blood Testing is...
author: Chiron Corporation
subject: For your convenience, printable versions of key information from various sections of our corporate site can be found here in PDF format. To the best of Chiron s knowledge, all information included is timely and accurate as of the date originally issued.
Chiron History
For more than 20 years, Chiron has been an industry leader, making groundbreaking scientific discoveries and creating revolutionary products that are improving human health worldwide. K.- based vaccines company, acquired. Food and Drug Administration (FDA) labeling approval for treating relapsing forms of multiple sclerosis. MENJUGATE ® , a groundbreaking conjugate...
author: Chiron Corporation
subject: For your convenience, printable versions of key information from various sections of our corporate site can be found here in PDF format. To the best of Chiron s knowledge, all information included is timely and accurate as of the date originally issued.
Chiron Corporation - Media - Fact Sheet
Through its global Blood Testing, Vaccines and BioPharmaceuticals businesses, Chiron Corporation addresses human suffering with more than 50 diverse products to detect, prevent and treat disease worldwide. The companys success has come from its pioneering science, skill in delivering innovations in biotechnology and disciplined business approach. Chiron Blood Testing...
Chiron Corporation - Media - Chiron History
For more than 20 years, Chiron has been an industry leader, making groundbreaking scientific discoveries and creating revolutionary products that are improving human health worldwide. PROCLEIX ® System , a state-of-the-art blood-screening product, launched in the United States. MENJUGATE ® , a groundbreaking conjugate vaccine against meningococcal C disease, approved in...
Chiron Corporation - Products
- - Chiron markets products through its three global business units: Blood Testing , Vaccines and BioPharmaceuticals. Vaccines Chiron Vaccines, the fifth-largest vaccines business in the world, currently offers more than 30 novel and conventional vaccines for adults and children. Food and Drug Administration and is not intended for use by customers, patients or health care...
Chiron Corporation - Patients - Infectious Disease
Chiron's focus on infectious-disease research has led to the development of breakthrough products in key areas of medical need: inhaled therapeutics, vaccines and blood screening. Chiron currently markets TOBI ® tobramycin solution for inhalation, the leading inhaled antibiotic for the most prevalent type of lung infection in cystic fibrosis patients, in the United...
Chiron Corporation - Research - Partnerships
- - In addition to the company's own research and development activities, Chiron develops technology and products in collaboration with several leading companies. Chiron also has agreements with Berna Biotech (formerly Rhein Biotech), S*BIO and Ortho-McNeil Pharmaceutical, among other firms. - In 1991, Chiron signed an agreement with Schering and its subsidiary Berlex to market...
Chiron Corporation - Business - Partnerships
- - In addition to the company's own research and development activities, Chiron develops technology and products in collaboration with several leading companies. Chiron also has agreements with Berna Biotech (formerly Rhein Biotech), S*BIO and Ortho-McNeil Pharmaceutical, among other firms. - In 1991, Chiron signed an agreement with Schering and its subsidiary Berlex to market...
Chiron Corporation - About Us - History
- - For more than 20 years, Chiron has been an industry leader, making groundbreaking scientific discoveries and creating revolutionary products that are improving human health worldwide. BETASERON ® INTERFERON BETA-1b gains expanded U.S. PROCLEIX ® System , a state-of-the-art blood-screening product, launched in the United States.TOBI ® tobramycin ...
Chiron Corporation - Research
- - Chiron is applying an advanced understanding of cancer and infectious disease to create high-value products that address major medical needs. The company has maintained and broadened its focus on infectious-disease research since its groundbreaking work with hepatitis B antigens in the early 1980s. Chiron is building strong product lines in its areas of scientific focus.
Chiron Corporation - Patients - Disease Area Information
The following resources have been compiled to help patients and caregivers better understand the illnesses they face and the treatment options available. Cystic Fibrosis -|- Hepatitis -|- Melanoma -|- Multiple Sclerosis -|- Renal Cell Carcinoma - Web Sites Abouttobi.com Chiron's site containing information about TOBI ® tobramycin solution for inhalation, the first...